97 related articles for article (PubMed ID: 8148798)
1. Gastrointestinal physiology-regulated dogs: utilization of a bioavailability study of a new thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]-diazepine, an antagonist of platelet-activating factor, and its preparations.
Sagara K; Yamada I; Kawazoe Y; Mizuta H; Shibata M
Biol Pharm Bull; 1994 Jan; 17(1):117-20. PubMed ID: 8148798
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability study of commercial sustained-release preparations of diclofenac sodium in gastrointestinal physiology regulated-dogs.
Sagara K; Nagamatsu Y; Yamada I; Kawata M; Mizuta H; Ogawa K
Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3303-6. PubMed ID: 1294333
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
Sagara K; Yamada I; Matsuura Y; Kawata M; Shibata M
Biol Pharm Bull; 1996 Sep; 19(9):1184-8. PubMed ID: 8889038
[TBL] [Abstract][Full Text] [Related]
4. Utility of gastrointestinal physiology regulated-dogs: bioavailability study of a commercial sustained-release dosage form of theophylline.
Sagara K; Kawata M; Mizuta H; Shibata M
Biol Pharm Bull; 1994 Jul; 17(7):931-4. PubMed ID: 8000380
[TBL] [Abstract][Full Text] [Related]
5. Determination of the platelet activating factor antagonist 6-(2- chlorophenyl)-9-[(4-methoxyphenyl)thiocarbamoyl]-1-methyl-7,8,9,10- tetrahydro-4H-pyrido[4',3'-4,5]-thieno[3,2-f][1,2,4]triazolo[4, 3-a][1,4] diazepine in human plasma by liquid chromatography-thermospray mass spectrometry.
Celma C
J Chromatogr B Biomed Appl; 1994 Jul; 657(1):214-8. PubMed ID: 7952071
[TBL] [Abstract][Full Text] [Related]
6. Development of radioimmunoassay for the novel platelet activating factor receptor antagonist, E6123, and its application to pharmacokinetics in laboratory animals.
Kusano K; Tadano K; Tanaka S; Kagei Y; Ueda M; Miyazawa S; Abe Y; Ida S; Yuzuriha T
Biol Pharm Bull; 1994 Feb; 17(2):334-9. PubMed ID: 8205134
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
8. Hapten synthesis for (+)-6-(2-chlorophenyl)-3-cyclopropanecarbonyl-8,11-dimethyl-2,3,4,5-tet rahydro-8H-pyrido[4',3':4,5]thieno[3,2-f] triazolo[4,3-a][1,4]diazepine (E6123).
Miyazawa S; Okano K; Kawahara T; Machida Y; Yamatsu I
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):762-5. PubMed ID: 1611690
[TBL] [Abstract][Full Text] [Related]
9. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
10. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a new thienodiazepine platelet activating factor receptor antagonist (E6123) in laboratory animals. Is there a metabolic polymorphism in the rhesus monkey?
Kusano K; Tanaka S; Abe Y; Ida S; Yuzuriha T
Xenobiotica; 1993 Jun; 23(6):589-98. PubMed ID: 8212733
[TBL] [Abstract][Full Text] [Related]
12. Dual effects of a novel thienodiazepine platelet-activating factor antagonist, on drug-oxidizing enzymes in beagle dog.
Tanaka E; Daling Z; Abe K; Nakamura T; Horie T
Xenobiotica; 1994 Apr; 24(4):293-300. PubMed ID: 8059533
[TBL] [Abstract][Full Text] [Related]
13. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
Kendall J; Papich MG
Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis.
Sakuma Y; Shirato M; Nagaoka J; Obaishi H; Tsunoda H; Katayama S; Ono H; Katayama K
Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526
[TBL] [Abstract][Full Text] [Related]
15. Y-24180, an antagonist of platelet-activating factor, suppresses interleukin 5 production in cultured murine th(2)cells and human peripheral blood mononuclear cells.
Kusuhara H; Yamaguchi S; Matsuyuki H; Sugahara K; Komatsu H; Terasawa M
Cytokine; 2000 Jul; 12(7):1120-3. PubMed ID: 10880261
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of bioavailability upon oral administration of phytonadione preparations in beagle dogs.
Tokumura T; Tsushima Y; Machida Y; Kayano M; Nagai T
Biol Pharm Bull; 1993 Mar; 16(3):319-21. PubMed ID: 8364482
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutics of didanosine in humans and in a model for acid-labile drugs, the pentagastrin-pretreated dog.
Knupp CA; Shyu WC; Morgenthien EA; Lee JS; Barbhaiya RH
Pharm Res; 1993 Aug; 10(8):1157-64. PubMed ID: 8415401
[TBL] [Abstract][Full Text] [Related]
18. Rapidly absorbed solid oral formulations of ibuprofen using water-soluble gelatin.
Imai T; Kimura S; Iijima T; Miyoshi T; Ueno M; Otagiri M
J Pharm Pharmacol; 1990 Sep; 42(9):615-9. PubMed ID: 1981899
[TBL] [Abstract][Full Text] [Related]
19. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
